Kamala Harris has declared that she will support cannabis legalisation in the US. What does this mean for the industry?

In this article we explore some new research which outlines the impact of stigma and inequality on medical cannabis patients in the UK.

The recent increase in ketamine use among young people, highlighted in The Guardian by Owen Bowden-Jones, has ignited concerns across the UK. While some experts, including Bowden-Jones, have described ...

The Medicines and Healthcare products Regulatory Agency (MHRA) is set to release comprehensive guidance across up to five different documents, covering key regulatory changes for Cannabis-Based ...

Welcome to August’s analysis of the MedBud traffic data. The most interesting month we have had yet, and a clear sign that the data we analyse provides a real time accurate representation of how the ...